Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Infectious Diseases|March 15, 2014
Possible options for new pertussis vaccinesBruce D Meade, Stanley A Plotkin, Camille Locht
Clinical and Diagnostic Laboratory Immunology|November 5, 2002
Use of coefficient of variation in assessing variability of quantitative assaysGeorge F Reed, Freyja Lynn, Bruce D Meade
Vaccine|November 30, 2019
Pertussis vaccines: The first hundred yearsNicole Guiso, Bruce D Meade, Carl Heinz Wirsing von König
Statistics in Medicine|December 14, 2005
Mixture model analysis for establishing a diagnostic cut-off point for pertussis antibody levelsAndrew L Baughman, Kristine M Bisgard, Freyja Lynn, et al.
Clinical and Vaccine Immunology : CVI|July 16, 2010
Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assaysRebecca A Brady, Anita Verma, Bruce D Meade, et al.
Clinical and Vaccine Immunology : CVI|April 9, 2010
Comparison of three anthrax toxin neutralization assaysMiriam M Ngundi, Bruce D Meade, Tsai-Lien Lin, et al.
Clinical and Vaccine Immunology : CVI|August 7, 2009
Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assaysAnita Verma, Miriam M Ngundi, Bruce D Meade, et al.
Clinical and Vaccine Immunology : CVI|December 26, 2008
Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative studyDorothy Xing, Carl Heinz Wirsing von König, Penny Newland, et al.
Clinical and Diagnostic Laboratory Immunology|November 13, 2004
Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United StatesAndrew L Baughman, Kristine M Bisgard, Kathryn M Edwards, et al.
Pageof 2